Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Health Catalyst Inc.

    NASDAQ: HCAT · Real-Time Price · USD
    3.85
    -0.10 (-2.53%)
    At close: Jun 05, 2025, 3:59 PM
    3.84
    -0.26%
    After-hours: Jun 05, 2025, 06:40 PM EDT

    Health Catalyst Statistics

    Share Statistics

    Health Catalyst has 69.6M shares outstanding. The number of shares has increased by 18.93% in one year.

    Shares Outstanding

    n/a
    		 69.6M

    Shares Change (YoY)

    n/a
    		 18.93%

    Shares Change (QoQ)

    n/a
    		 15.39%

    Owned by Institutions (%)

    n/a
    		 85.72%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 138

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 3.21M, so 4.61% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.21M

    Short % of Shares Out

    n/a
    		 4.61%

    Short % of Float

    n/a
    		 5.26%

    Short Ratio (days to cover)

    n/a
    		 5.67

    Valuation Ratios

    The PE ratio is -6.12 and the forward PE ratio is 10.15. Health Catalyst's PEG ratio is 0.14.

    PE Ratio

    n/a
    		 -6.12

    Forward PE

    n/a
    		 10.15

    PS Ratio

    n/a
    		 1.39

    Forward PS

    n/a
    		 0.6

    PB Ratio

    n/a
    		 1.17

    P/FCF Ratio

    n/a
    		 -231.38

    PEG Ratio

    n/a
    		 0.14
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Health Catalyst.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.43, with a Debt / Equity ratio of 1.1.

    Current Ratio

    n/a
    		 1.43

    Quick Ratio

    n/a
    		 1.43

    Debt / Equity

    n/a
    		 1.1

    Debt / EBITDA

    n/a
    		 -14.84

    Debt / FCF

    n/a
    		 -218.74

    Interest Coverage

    n/a
    		 -4.09

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $204,389.33

    Profits Per Employee

    n/a
    		 $-46,334.67

    Employee Count

    n/a
    		 1,500

    Asset Turnover

    n/a
    		 0.36

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 333K

    Effective Tax Rate

    n/a
    		 -0.48%

    Stock Price Statistics

    The stock price has increased by -41.84% in the last 52 weeks. The beta is 1.53, so Health Catalyst's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.53

    52-Week Price Change

    n/a
    		 -41.84%

    50-Day Moving Average

    n/a
    		 4.01

    200-Day Moving Average

    n/a
    		 6.21

    Relative Strength Index (RSI)

    n/a
    		 46.64

    Average Volume (20 Days)

    n/a
    		 605,817

    Income Statement

    In the last 12 months, Health Catalyst had revenue of 306.58M and earned -69.5M in profits. Earnings per share was -1.15.

    Revenue

    n/a
    		 306.58M

    Gross Profit

    n/a
    		 140.78M

    Operating Income

    n/a
    		 -69.81M

    Net Income

    n/a
    		 -69.5M

    EBITDA

    n/a
    		 -27.1M

    EBIT

    n/a
    		 -68.53M

    Earnings Per Share (EPS)

    n/a
    		 -1.15
    Full Income Statement

    Balance Sheet

    The company has 249.65M in cash and 402.26M in debt, giving a net cash position of -152.62M.

    Cash & Cash Equivalents

    n/a
    		 249.65M

    Total Debt

    n/a
    		 402.26M

    Net Cash

    n/a
    		 -152.62M

    Retained Earnings

    n/a
    		 -1.19B

    Total Assets

    n/a
    		 891.54M

    Working Capital

    n/a
    		 83.16M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 14.56M and capital expenditures -16.4M, giving a free cash flow of -1.84M.

    Operating Cash Flow

    n/a
    		 14.56M

    Capital Expenditures

    n/a
    		 -16.4M

    Free Cash Flow

    n/a
    		 -1.84M

    FCF Per Share

    n/a
    		 -0.03
    Full Cash Flow Statement

    Margins

    Gross margin is 45.92%, with operating and profit margins of -22.77% and -22.67%.

    Gross Margin

    n/a
    		 45.92%

    Operating Margin

    n/a
    		 -22.77%

    Pretax Margin

    n/a
    		 -22.56%

    Profit Margin

    n/a
    		 -22.67%

    EBITDA Margin

    n/a
    		 -8.84%

    EBIT Margin

    n/a
    		 -22.77%

    FCF Margin

    n/a
    		 -0.6%

    Dividends & Yields

    HCAT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for HCAT is $6.25, which is 62.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $6.25

    Price Target Difference

    n/a
    		 62.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 11
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.51

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist